Abstract |
MicroRNAs (miR) are a class of small ( approximately 21 nucleotide) noncoding RNAs that, in general, negatively regulate gene expression. Some miRs harboring CGIs undergo methylation-mediated silencing, a characteristic of many tumor suppressor genes. To identify such miRs in liver cancer, the miRNA expression profile was analyzed in hepatocellular carcinoma (HCC) cell lines treated with 5-azacytidine ( DNA hypomethylating agent) and/or trichostatin A ( histone deacetylase inhibitor). The results showed that these epigenetic drugs differentially regulate expression of a few miRs, particularly miR-1-1, in HCC cells. The CGI spanning exon 1 and intron 1 of miR-1-1 was methylated in HCC cell lines and in primary human HCCs but not in matching liver tissues. The miR-1-1 gene was hypomethylated and activated in DNMT1-/- HCT 116 cells but not in DNMT3B null cells, indicating a key role for DNMT1 in its methylation. miR-1 expression was also markedly reduced in primary human hepatocellular carcinomas compared with matching normal liver tissues. Ectopic expression of miR-1 in HCC cells inhibited cell growth and reduced replication potential and clonogenic survival. The expression of FoxP1 and MET harboring three and two miR-1 cognate sites, respectively, in their respective 3'-untranslated regions, was markedly reduced by ectopic miR-1. Up-regulation of several miR-1 targets including FoxP1, MET, and HDAC4 in primary human HCCs and down-regulation of their expression in 5-AzaC-treated HCC cells suggest their role in hepatocarcinogenesis. The inhibition of cell cycle progression and induction of apoptosis after re-expression of miR-1 are some of the mechanisms by which DNA hypomethylating agents suppress hepatocarcinoma cell growth.
|
Authors | Jharna Datta, Huban Kutay, Mohd W Nasser, Gerard J Nuovo, Bo Wang, Sarmila Majumder, Chang-Gong Liu, Stefano Volinia, Carlo M Croce, Thomas D Schmittgen, Kalpana Ghoshal, Samson T Jacob |
Journal | Cancer research
(Cancer Res)
Vol. 68
Issue 13
Pg. 5049-58
(Jul 01 2008)
ISSN: 1538-7445 [Electronic] United States |
PMID | 18593903
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Retracted Publication)
|
Chemical References |
- Antineoplastic Agents
- Enzyme Inhibitors
- Histone Deacetylase Inhibitors
- MicroRNAs
- DNA (Cytosine-5-)-Methyltransferases
|
Topics |
- Antineoplastic Agents
(pharmacology)
- Apoptosis
(genetics)
- Carcinoma, Hepatocellular
(genetics)
- Cell Cycle
(genetics)
- Cell Proliferation
- Cluster Analysis
- CpG Islands
(drug effects, genetics)
- DNA (Cytosine-5-)-Methyltransferases
(antagonists & inhibitors)
- DNA Methylation
- Disease Progression
- Enzyme Inhibitors
(pharmacology)
- Gene Expression Profiling
- Gene Expression Regulation, Neoplastic
- Gene Silencing
(drug effects, physiology)
- HCT116 Cells
- Histone Deacetylase Inhibitors
- Humans
- Liver Neoplasms
(genetics)
- MicroRNAs
(genetics, physiology)
- Oligonucleotide Array Sequence Analysis
- Phenotype
- Transfection
- Tumor Cells, Cultured
|